IFP Advisors’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.7K Buy
711
+250
+54% +$4.48K ﹤0.01% 2787
2025
Q1
$8.22K Sell
461
-15
-3% -$267 ﹤0.01% 2651
2024
Q4
$14.2K Buy
476
+17
+4% +$507 ﹤0.01% 2402
2024
Q3
$7.18K Sell
459
-42
-8% -$657 ﹤0.01% 2548
2024
Q2
$8.58K Hold
501
﹤0.01% 2389
2024
Q1
$7.83K Sell
501
-89
-15% -$1.39K ﹤0.01% 2321
2023
Q4
$8.81K Buy
590
+460
+354% +$6.87K ﹤0.01% 2235
2023
Q3
$2.1K Buy
130
+49
+60% +$792 ﹤0.01% 2826
2023
Q2
$3.36K Sell
81
-1,305
-94% -$54.2K ﹤0.01% 2681
2023
Q1
$44.3K Sell
1,386
-2,175
-61% -$69.5K ﹤0.01% 1641
2022
Q4
$123K Buy
3,561
+18
+0.5% +$622 ﹤0.01% 1634
2022
Q3
$121K Buy
3,543
+12
+0.3% +$410 ﹤0.01% 1722
2022
Q2
$120K Hold
3,531
﹤0.01% 1576
2022
Q1
$120K Buy
3,531
+1,331
+61% +$45.2K ﹤0.01% 1576
2021
Q4
$169K Buy
2,200
+181
+9% +$13.9K ﹤0.01% 1020
2021
Q3
$236K Sell
2,019
-3
-0.1% -$351 ﹤0.01% 848
2021
Q2
$449K Sell
2,022
-40
-2% -$8.88K 0.01% 579
2021
Q1
$273K Sell
2,062
-378
-15% -$50K 0.01% 711
2020
Q4
$421K Buy
2,440
+579
+31% +$99.9K 0.02% 556
2020
Q3
$204K Sell
1,861
-110
-6% -$12.1K 0.01% 695
2020
Q2
$116K Buy
1,971
+149
+8% +$8.77K 0.01% 866
2020
Q1
$125K Buy
1,822
+638
+54% +$43.8K 0.01% 737
2019
Q4
$103K Buy
1,184
+389
+49% +$33.8K 0.01% 932
2019
Q3
$59K Buy
+795
New +$59K ﹤0.01% 1293
2019
Q1
$2K Sell
35
-1,726
-98% -$98.6K ﹤0.01% 2098
2018
Q4
$58K Buy
1,761
+96
+6% +$3.16K ﹤0.01% 1509
2018
Q3
$87K Buy
1,665
+1,100
+195% +$57.5K ﹤0.01% 1565
2018
Q2
$18K Buy
+565
New +$18K ﹤0.01% 2499
2016
Q2
Sell
-35
Closed -$2K 4080
2016
Q1
$2K Buy
+35
New +$2K ﹤0.01% 2098